[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340953-105":59,"doc-detail-340953-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","macrophages-reprogramming-improves-immunotherapy-of-il-33-in-peritoneal-metastasis-of-gastric-cancer","Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer","","Peritoneal metastasis creates a suppressive tumor immune microenvironment that limits immunotherapy efficacy in gastric cancer. This study evaluates intraperitoneal IL-33 administration, aiming to enhance antitumor immunity and restrain metastatic progression. High IL-33 mRNA expression correlates with prolonged survival in patients. In immunocompetent mice, IL-33 induces a local inflammatory state, activates immunologic effector cells, and reverses immunosuppression, delaying tumor progression. Mechanistically, IL-33 triggers M2 polarization via p38-GATA-binding protein 3 signaling, and combining IL-33 with anti-CSF1R or p38 inhibition synergistically reprograms tumor-associated macrophages to improve treatment outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/macrophages-reprogramming-improves-immunotherapy-of-il-33-in-peritoneal-metastasis-of-gastric-cancer/340953/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/macrophages-reprogramming-improves-immunotherapy-of-il-33-in-peritoneal-metastasis-of-gastric-cancer/340953.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study target in gastric cancer peritoneal metastasis?","Question",{"text":112,"@type":113},"The study targets the suppressive tumor immune microenvironment in peritoneal metastasis that limits immunotherapy effectiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does intraperitoneal IL-33 affect the tumor immune microenvironment?",{"text":117,"@type":113},"It induces a local inflammatory environment, activates immunologic effector cells, and reverses the immunosuppressive tumor microenvironment, delaying tumor progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism is proposed for IL-33-driven macrophage polarization?",{"text":121,"@type":113},"IL-33 promotes M2 polarization through activation of the p38-GATA-binding protein 3 signaling pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340953,1790171549,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Article  \nMacrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer  \nKeying Che 1,2,3, Yuting Luo1, Xueru Song1, Zhe Yang3, Hanbing Wang1, Tao Shi 1, Yue Wang1, Xuan Wang1,4, Hongyan Wu5, Lixia Yu1, Baorui Liu1 & Jia Wei 1,2,6,7 ✉  \nAbstract  \nPeritoneal metastasis (PM) has a suppressive tumor immune microenvironment (TIME) that limits the effects of immunotherapy. This study aimed to investigate the immunomodulatory effects of intraperitoneal administration of IL-33, a cytokine that is reported to potentiate antitumor immunity and inhibit metastasis. We found survival was signiﬁcantly prolonged in patients with high IL-33 mRNA expression. In immunocompetent mice, intraperitoneal administration of IL-33 could induce a celiac inﬂammatory environment, activate immunologic effector cells, and reverse the immunosuppressive tumor microenvironment, which effectively delayed tumor progression and PM of gastric cancer. Mechanistically, IL-33 could induce M2 polarization by activating p38-GATA-binding protein 3 signaling. IL-33 combined with anti-CSF1R or p38 inhibitor to regulate tumor-associated macrophages (TAMs) had a synergistic antitumor effect. Inducing a local inﬂammatory milieu by IL-33 administration provided a novel approach for treating peritoneal metastasis, which, when combined with TAM reprogramming to reshape TIME, can achieve better treatment efﬁcacy.  \nKeywords IL-33; Gastric Cancer; Peritoneal Metastasis; Tumor Immune Microenvironment; Tumor-associated Macrophages  \nSubject Categories Cancer; Digestive System; Immunology  \n[https://doi.org/10.1038/s44321-023-00012-y](https://doi.org/10.1038/s44321-023-00012-y)  \nReceived 18 December 2022; Revised 24 September 2023; Accepted 20 November 2023  \nPublished online: 18 January 2024  \nIntroduction  \nGastric cancer (GC) is the sixth most common cancer and the third leading cause of cancer-related deaths globally, resulting in 1 million newly diagnosed cases and an estimated 800,000 deaths yearly (Sung et al, 2021) . Peritoneal metastasis (PM) is the most common form of recurrence and metastasis in patients with GC  \n(Dong et al, 2019) . Approximately, 53–66% of patients diagnosed with distant metastatic GC present with PM, which is associated with a dismal 5-year survival rate of 6.0% (Rau et al, 2020) . Although surgery and chemotherapy can improve the clinical prognosis of patients, the commonly used therapeutic measures for GC with PM are still unsatisfactory. Recent advances in genomic sequencing and molecular proﬁling have revealed several promising therapeutic targets and elucidated novel biology, particularly the role of the surrounding tumor immune microenvironment (TIME) in PM of GC (Gwee et al, 2022) .  \nPM is limited to the abdominal cavity; therefore, the local administration of therapeutic agents can achieve higher drug concentrations with a few systemic adverse effects. In recent years, intraperitoneal chemotherapy and local cytokine therapy have been explored in peritoneal tumors (Bonnot et al, 2019; Iwamura et al, 2017) . Interleukin (IL)-33 is a cytokine of the IL-1 superfamily that triggers a MyD88-dependent acute inﬂammatory response through its surface receptor ST2 (Kita, 2022) . MyD88 binding recruits IL-1 receptor-associated kinase and tumor necrosis factor receptorassociated factor 6-activating nuclear factor–kappa B (NF-κB) pathway, which promote inﬂammatory cytokine expression. Meanwhile, IL-33 signaling has been demonstrated to enhance the expression of forkhead box-P3 and GATA-binding protein 3  \n(GATA3) by enhancing transforming growth factor β1 (TGF-β1) -mediated differentiation through a p38-dependent mechanism (Griesenauer and Paczesny, 2017) . Previous studies have indicated that IL-33 predominantly induces a type 2 immune response and is closely associated with allergic and parasitic diseases (Chan et al, 2019) . It has recently been reported that IL-33 potentiatesantitumor immunity by promoting inﬂ","cbCaibbn75cs7qW5","https://ap.wps.com/l/cbCaibbn75cs7qW5","pdf",4009355,16,"English","# Introduction\n## Rationale for peritoneal metastasis and local therapy\n## IL-33 biology and immunotherapy potential\n# Macrophages and macrophage polarization","[{\"question\":\"What problem does the study target in gastric cancer peritoneal metastasis?\",\"answer\":\"The study targets the suppressive tumor immune microenvironment in peritoneal metastasis that limits immunotherapy effectiveness.\"},{\"question\":\"How does intraperitoneal IL-33 affect the tumor immune microenvironment?\",\"answer\":\"It induces a local inflammatory environment, activates immunologic effector cells, and reverses the immunosuppressive tumor microenvironment, delaying tumor progression.\"},{\"question\":\"What mechanism is proposed for IL-33-driven macrophage polarization?\",\"answer\":\"IL-33 promotes M2 polarization through activation of the p38-GATA-binding protein 3 signaling pathway.\"}]","Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer | PDF",1790039670,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8853fae2db8cfd136f56f04377332272.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e20ef80678d902a5c3af70a296d1992e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2d366708b345d2a5394eb0a57065e71.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb1cf44f65cd1ca71b65430f020f0e99.webp",980,1301]